Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease

Meilan Xian, Jiaoyuan Xu, Yamei Zheng, Lei Zhang, Jie Zhao, Jie Chen, Siguang Li, Lingsang Lin, Yi Zhong, Zehua Yang, Tian Xie, Linhui Huang, Yipeng DingInternational Journal of COPD 2024 · DOI

Abstract

These findings indicate that CBM may modulate the expression of <i>SRC, ADRB2, MMP2</i>, and <i>NOS3</i>, thereby exerting a protective effect against COPD.
BibTeX
@article{xian2024network,
  author = {Meilan Xian and Jiaoyuan Xu and Yamei Zheng and Lei Zhang and Jie Zhao and Jie Chen and Siguang Li and Lingsang Lin and Yi Zhong and Zehua Yang and Tian Xie and Linhui Huang and Yipeng Ding},
  title = {{Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease}},
  journal = {International Journal of COPD},
  year = {2024},
  doi = {10.2147/copd.s442191},
}

Loading related content...

Figure